LWLena Westh

Lena Westh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lena Westh has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Ann-Brit Eg Hansen

    Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

    1 shared publication
  • Bjarne K. Møller

    International Center for Immunodeficiency Diseases, Aarhus University Hospital Skejby, Aarhus, Denmark; Department of Clinical Immunology, Aarhus University Hospital, Skejby, Aarhus, Denmark

    1 shared publication
  • Britta Tarp

    Diagnostic Centre, University Research Clinic for Innovative Patient Pathways, Silkeborg Regional Hospital, Silkeborg, Denmark

    1 shared publication
  • C. S. Larsen

    Department of Infectious Diseases, Aarhus University Hospital Skejby, Aarhus, Denmark

    1 shared publication
  • Carsten S. Larsen

    International Center for Immunodeficiency Diseases, Aarhus University Hospital Skejby, Aarhus, Denmark; Department of Infectious Diseases, Aarhus University Hospital, Skejby, Aarhus, Denmark

    1 shared publication
  • Carsten Schade Larsen

    1 shared publication

Latest Publications

  • Identification and Characterization of a Nationwide Danish Adult Common Variable Immunodeficiency Cohort

    by L. Westh, T. H. Mogensen, L. S. Dalgaard, J. M. Bernth Jensen, T. Katzenstein, A.‐B. E. Hansen, O. D. Larsen, S. Terpling, T. L. Nielsen, C. S. Larsen

    In this study, we identified all adults living in Denmark diagnosed with common variable immunodeficiency (CVID) and characterized them according to clinical presentation and EUROclass classification. Using a retrospective, cross‐sectional design, possible CVID patients were identified in the Danish National Patient Register and Centers in Denmark treating patients with primary immunodeficiencies. The CVID diagnosis was verified by review of medical records. One‐hundred‐seventy‐nine adults with CVID were identified. This corresponds to a prevalence of 1:26,000. The median age at onset of symptoms was 29 years with no sex difference. The median age at diagnosis was 40 years. Males were diagnosed earlier with a peak in the fourth decade of life, whereas females were diagnosed later with a peak in the sixth decade. The median diagnostic delay was seven years. Recurrent sinopulmonary infections were seen in 92.7% of the patients. The prevalence of non‐infectious complications was similar to that of previously reported cohorts: bronchiectasis (35.8%), splenomegaly (22.4%), lymphadenopathy (26.3%), granulomatous inflammation (3.9%) and idiopathic thrombocytopenic purpura (14.5%). Non‐infectious complications were strongly associated with B cell phenotype, with all having a reduced number of isotype‐switched memory B cells. One‐hundred‐seventy (95%) were treated with immunoglobulin replacement therapy, primarily administered subcutaneously. According to international guidelines, diagnostic evaluation was inadequate in most cases. This study emphasizes the need for improved diagnostic criteria and more awareness of CVID as a differential diagnosis. Diagnosis and management of CVID patients is a challenge requiring specialists with experience in the field of PID.


    • 1 January 2017
      • Vol. 64  (1)

    Rotavirus is frequent among adults hospitalised for acute gastroenteritis.

    by Karen Rokkedal Lausch, Lena Westh, Lena Hagelskjær Kristensen, Jens Lindberg, Britta Tarp, Carsten Schade Larsen

    Rotavirus infection is the most common aetiology of acute gastroenteritis (AGE) among young children. In adults, diagnostics focus mainly on bacterial causes, though recent studies suggest that rotavirus is a frequent agent. The aim of this study was to examine the proportion of rotavirus in adults hospitalised with AGE and to identify possible predictors. During a 24-month period from 1 May 2010 adults (> 15 years) with AGE admitted to one of four hospitals in the Central Denmark Region were examined for rotavirus with VIKIA Rota-Adeno rapid test in addition to routine culture for bacterial pathogens. A total of 265 adult patients were included. 9.4% tested positive for rotavirus. Enteropathogenic bacteria were found in 24.5% of the cases. In the majority of cases (62.3%), no pathogen was found. Overall, rotavirus was the second-most frequent pathogen, exceeded only by Campylobacter spp. Immunosuppression and a C-reactive protein (CRP) below 50 mg/l (0-8 mg/l) were associated with rotavirus. The seasonality of rotavirus differed markedly from that of bacterial gastroenteritis. Rotavirus is the second-most frequently identified pathogen in adults hospitalised with AGE. Close contact to children or travel activity does not predict rotavirus gastroenteritis, but immunosuppression and a CRP below 50 mg/l do. The seasonality of rotavirus differs from that of bacterial gastroenteritis, making rotavirus the most frequently identified cause of AGE in adults admitted to hospital in the colder months. The trial was funded by an unrestricted grant from Sanofi Pasteur MSD. not relevant.


  • Altered fraction of regulatory B and T cells is correlated with autoimmune phenomena and splenomegaly in patients with CVID

    by Emil Kofod-Olsen, Sofie Eg Jørgensen, Sara Konstantin Nissen, Lena Westh, Bjarne K. Møller, Lars Østergaard, Carsten S. Larsen, Trine H. Mogensen